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Abnormal signaling by retinoids or n-3 polyunsatu-
rated fatty acids has been implicated in clinical
depression. The converging point in activities of
these two classes of molecules is transcriptional
activation of retinoid X receptors (Rxr). We show
here that ablation of Rxrg in mice leads to depres-
sive-like behaviors including increased despair and
anhedonia, which were accompanied by reduced
expression of dopamine D2 receptor in the shell of
nucleus accumbens (NAc) and altered serotonin
signaling. While abnormal serotonin signaling is not
sufficient to generate the depressive behaviors,
increasing D2r expression by chronic fluoxetine
(Prozac) treatment or adenoassociated virus type2
(AAV2) mediated expression of Rxrg or D2r in
the NAc of Rxrg/ mice normalizes depressive-like
behaviors in Rxrg/ animals. Conversely, NAc infu-
sion of raclopride, a D2r antagonist prevents
AAV2-Rxrg-mediated rescue of despair behaviors
in Rxrg/ mice. Combined, our data argue that
control of NAc D2r expression is critical for Rxrg-
mediated modulation of affective behaviors.
INTRODUCTION
Dopaminergic signaling and in particular its mesolimbic pathway
plays an important, reinforcing role in regulation of motivated
behaviors. Abnormally low dopaminergic signaling has been
suggested to be involved in clinical depression (Millan, 2006;
Nestler and Carlezon, 2006). Classical antidepressant treat-
ments increase dopaminergic tone and its signaling via different
dopamine receptor subtypes, which suggests a direct implica-
tion of dopamine in the efficiency of such treatments (Renard
et al., 2001; Valentini et al., 2004; Willner et al., 2005). The dopa-
minergic reuptake inhibitor, Bupropion, has been found effective
as an antidepressant treatment (Foley et al., 2006), although its908 Neuron 66, 908–920, June 24, 2010 ª2010 Elsevier Inc.actions also implicate noradrenergic transmission. Furthermore,
some of the dopaminergic receptor ligands, such as bromocrip-
tine and pergolide or pramipexole, are effective in the treatment
of depression either as a monotherapy or as adjuvants (Corrigan
et al., 2000; Mattes, 1997; Theohar et al., 1982). Although the
dopamine receptor specificity of these agents is variable, all of
them act as agonists of dopamine D2 receptor (D2r), which
suggests that this receptor plays a particular role in the regula-
tion of affective behaviors. This possibility is further supported
by preclinical studies in rodent models used for research on
depression. Thus, chronic mild stress leads to a reduction of
D2r expression in the nucleus accumbens (Willner, 1997), and
activation of D2 receptors has an anti-depressant action in
animal models of despair (Brocco et al., 2006; Siuciak and
Fujiwara, 2004). Moreover, chronic antidepressant treatments
including selective serotonin reuptake inhibitors (SSRIs), which
primarily modulate serotonergic transmission, can also increase
D2r expression in humans and rodents (Ainsworth et al., 1998;
Dziedzicka-Wasylewska et al., 1997; Larisch et al., 1997). In
line with such findings, an inhibition of D2r in human and animal
models prevents antidepressant activities of fluoxetine (Prozac)
and/or other antidepressants (Willner et al., 2005, and references
therein).
The expression of D2r is modulated at the transcriptional level
by retinoic acid (RA), an active form of vitamin A (Krezel et al.,
1998; Samad et al., 1997). Such control implicates activities of
retinoic acid receptors (Rara, Rarb, Rarg) and retinoid X recep-
tors (Rxra, Rxrb, Rxrg), which in the form of heterodimers act
as transcription factors and mediate RA signaling in vivo (Kastner
et al., 1997). Rarb and Rxrg are the predominant retinoid recep-
tors expressed in the striatum, including the nucleus accumbens
(Krezel et al., 1999; Zetterstro¨m et al., 1999). Concomitant abla-
tion of these receptors inRarb/Rxrg double-knockout mice leads
to strong reduction of D2r expression in the dorsal and ventral
striatum and marked locomotor deficits (Krezel et al., 1998).
The involvement of murine retinoid receptors in the control of
dopaminergic signaling in the striatum might suggest a potential
role of the retinoid pathway in modulation of affective behaviors.
Such modulation is further suggested by clinical data on depres-
sion associated with altered retinoid signaling in acne vulgaris
patients treated with isotretinoin (Bremner and McCaffery,
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Figure 1. Increased Despair Behavior in Rxrg/ Null Mutant Mice Is
Reversible by Chronic Antidepressant Treatment
The time of immobility in the forced swim test was measured in naive nWT = 6
and nRarb/ = 8, nRxrg/ = 8 single- and nRarb/Rxrg/ = 8 double-mutant
littermates (A). Chronic, 21-day long treatment with fluoxetine (20 mg/kg/
24 hr) reduced the immobility time in nRxrg/ = 10 mice as compared to
nRxrg/ = 10 mice fed with control diet but not in nWT = 8 mice as
compared to nWT = 11 mice fed with control diet (B). Data are presented as
mean values ± SEM. ***p < 0.001 with respect to nontreated (A) or vehicle-
treated (B) WT mice; ##p < 0.01 as compared with vehicle-treated Rxrg/
mice. See also Figure S1.
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Retinoid Receptors Control Motivated Behaviors2008). Rxr’s were also proposed to mediate genomic actions of
n-3 polyunsaturated fatty acids (n-3 PUFAs) (de Urquiza et al.,
2000; Lengqvist et al., 2004). Such functions of Rxrs could be
directly relevant for the pathology of affective disorders, as
decreased n-3 PUFA signaling has been suggested to be
associated with depression and use of n-3 PUFAs such as doco-
sahexaenoic acid or eicosapentaenoic acid were reported
beneficial in clinical conditions (Logan, 2004; Peet and Stokes,
2005) and in animal models used in research on depression
(Carlezon et al., 2005; Naliwaiko et al., 2004). We have combined
pharmacological and genetic approaches to address the role of
retinoid receptors in control of affective behaviors and implica-
tion of dopaminergic signaling in such control.
RESULTS
Increased Despair Behaviors in Rxrg Null Mice Can
Be Normalized by Antidepressant Treatment
To address the contribution of retinoid receptors in control of
despair behaviors we have studied the effects of the loss of func-
tion of Rarb and/or Rxrg in mice on performance in the forced
swim test. Concomitant ablation of Rarb and Rxrg in Rarb/
Rxrg/ double null mutant mice led to a marked increase of
the immobility time, which attained 129 ± 4.3 s and was signifi-
cantly longer (p < 0.001) than in wild-type (WT) control mice,
which remained immobile for 71 ± 6.2 s (Figure 1A). The
increased immobility in the double-mutant mice was principally
due to the loss of function of Rxrg, since single Rxrg/ mutants
displayed similar high immobility time of 117 ± 4 s, whereas inac-
tivation of Rarb did not affect immobility time in this task (64.9 ±
6.8 s; p > 0.05). An abnormal locomotor behavior is unlikely to
account for the increased immobility time of Rxrg/ mice in
the forced swim test, since Rxrg/ mice did not differ from their
WT littermates with respect to spontaneous locomotion in acti-
metric cages, novelty-induced locomotion in the open field
test, or locomotor coordination in the rotarod task (Krezel
et al., 1998; see Figure S1 available online).
Since despair behaviors belong to the core symptoms of
depression, we have explored whether antidepressant treatment
could improve the performance of Rxrg/ mice. In agreement
with previous reports of SSRI activities in C57BL6J and 129SV
mouse strains (Dulawa et al., 2004), a 21 day chronic treatment
with fluoxetine at the dose of 20 mg/kg/24hr did not affect perfor-
mance of WT mice in the forced swim test, but such treatment
reversed the despair behavior in Rxrg/ mice (Figure 1B),
as illustrated by a significant genotype 3 fluoxetine treatment
interaction (F[1,35] = 23.2, p < 0.001). Thus, high immobility of
vehicle treated Rxrg/ mice was reduced in fluoxetine treated
Rxrg/ animals, which behaved comparably to vehicle treated
WT mice (Figure 1B).
Inactivation of Rxrg Leads to Anhedonia, Which Can
Be Normalized by Antidepressant Treatment
To better evaluate the involvement of retinoid receptors in the
control of affective behaviors, we investigated hedonic behav-
iors in the sucrose preference test in Rarb/ and Rxrg/ single
and compound mutant mice. During the active, night phase of
the circadian cycle WT mice displayed clear preference fora 1% sucrose solution as compared to plain water, since sucrose
represented 91.3% ± 2.7% of total liquid consumption. In
compound Rarb/Rxrg/ mutant mice, such a preference
was absent as sucrose consumption reached 58.1% ± 10.6%
of total liquid intake (Figure 2A), which was significantly less
than preference in WT mice (p < 0.05) and not different from
a chance level of 50% (t =0.1, ns, one-group t test). Such anhe-
donic behavior was due to ablation ofRxrg, sinceRxrg single null
mutants displayed similar loss of sucrose preference and con-
sumed 57.8% ± 10.8% of sucrose solution, whereas Rarb/
mice consumed sucrose solution at 92% ± 2.1% and were
indistinguishable from their WT controls. The total liquid intake
during the sucrose preference test was not different between
WT and mutant mice (4.6 ± 0.2 g for WT, 4.9 ± 0.3 for Rarb/,
4.9 ± 0.2 for Rxrg/ and 5.2 ± 0.3 for Rarb/Rxrg/
mutants). The absence of sucrose preference in Rarb/
Rxrg/ and Rxrg/ mice is unlikely to result from gustative
deficits since all groups preferred water to 1% sucrose on the
first presentation of sucrose drink. Thus, during 3 hr of the firstNeuron 66, 908–920, June 24, 2010 ª2010 Elsevier Inc. 909
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Figure 2. Loss of Sucrose Preference in Rxrg/ Mice Is Reversible
by Chronic Antidepressant Treatment
Sucrose preference was measured as percent of sucrose solution consump-
tion with respect to total amount of liquid consumed during the night phase
in nWT = 11 and nRarb/ = 11, nRvg/ = 7, and nRarb/Rxrg/ = 7 null mutant
mice (A). Chronic, 19-day long treatment with fluoxetine (20 mg/kg/24 hr)
normalized sucrose preference in nRxrg/ = 18 mice as compared to
nRXRg/ = 22 mice fed with control diet but not in nWT = 13 mice as compared
to nWT = 15 mice fed with control diet (B). Data are presented as mean values ±
SEM. *p < 0.05 significantly different from WT group; **p < 0.01 different from
vehicle treated WT mice.
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Figure 3. Abnormal Serotonergic Signaling Is Not Sufficient to
Generate Despair Behavior in Rxrg/ Mice
Total tissue levels of 5HT were standardized by tissue weight and compared
for the hippocampus and striatum in nWT = 6 and nRxrg/ = 6 mice (A). For
the same animals and structures the serotonin turnover was calculated as ratio
of standardized measures of 5HIAA and 5HT (B). Acute treatment with fluoxe-
tine (20 mg/kg) did not alter immobility time in the forced swim test neither in
nRxrg/ = 8 mice as compared to nRxrg/ = 8 vehicle-treated mice nor in
nWT = 7 mice as compared to nWT = 9 vehicle-treated mice (C), whereas the
same dose significantly reduced immobility time in control strain of nBALBc =
6 mice as compared to nBALBc = 6 vehicle-treated mice (D). Data are presented
as mean values ± SEM. *p < 0.05 or **p < 0.01 for selected comparisons and
***p < 0.001 in comparison with vehicle treated BALBc mice.
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Retinoid Receptors Control Motivated Behaviorstesting session, in sucrose-naive WT mice sucrose solution
constituted 43% ± 2.5% of total liquid consumption, as
compared to 44% ± 2.1% for Rarb/, 37% ± 5% for Rxrg/,
and 32.4% ± 7.3% forRarb/Rxrg/ mice, which for all groups
was significantly less than the chance level of 50% (t > 3.5 for any
of the comparisons, p < 0.05, one-group t test). Such avoidance
of sucrose solution by sucrose-naive mice results from a natural
tendency for reserved consumption of novel food/drink and
provides evidence for recognition of 1% sucrose taste. A
chronic, 19 day antidepressant treatment with 20 mg/kg/24hr
of fluoxetine, reversed the sucrose preference deficits in
Rxrg/ mice (Figure 2B), which is reflected by significant
genotype 3 treatment interaction (F[1,64] = 7.9, p < 0.01).
Thus, fluoxetine-treated Rxrg/ mice preferred sucrose solu-
tion to water similarly to WT control mice, and the percentage
of sucrose solution consumed by fluoxetine-treated Rxrg/
mice was significantly higher than in vehicle-treated mutant
animals (p < 0.001).910 Neuron 66, 908–920, June 24, 2010 ª2010 Elsevier Inc.Abnormal Serotonergic Signaling Is Not Sufficient
to Generate Depressive Behaviors in Rxrg/ Mice
Efficiency of fluoxetine to reverse affective abnormalities could
suggest that altered serotonergic signaling is at the origin of
depressive-like behaviors inRxrg/mice. To address this issue,
we carried out global evaluation of serotonergic signaling
focusing on hippocampus and striatum (including NAc), the
two regions differentially innervated by dorsal and median raphe
5HT inputs suggested to play a role in control of affect (Lechin
et al., 2006). HPLC measurements of 5HT and its metabolite
5HIAA in tissue homogenates revealed a significant increase of
5HT levels in the striatum of Rxrg/ mice (2.01 ± 0.18 ng/g for
Rxrg/ and 1.46 ± 0.17 for WT mice; t = 2.2, p = 0.05), which
was not accompanied by altered metabolism of serotonin
(Figure 3A). Although there was no significant difference in 5HT
levels in the hippocampus, Rxrg/ displayed strong tendency
(t = 1.92, p = 0.08) for increased metabolism of 5HT in this region
(Figure 3B). Such abnormalities in the distribution of 5HT did not
correlate with abnormal expression of 5HT1a receptor, promi-
nently involved in control of 5HT tone and proposed to play
a role in control of affective behaviors and in actions of SSRI anti-
depressants (Blier et al., 1998; Blier and Ward, 2003). Indeed, the
relative 5HT1a mRNA levels (standardized with respect to
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Figure 4. Decreased Expression of Dopa-
mineD2r ReceptormRNA in theNucleus Ac-
cumbens of Rxrg/ Mice Is Reversed by
Chronic Fluoxetine Treatment
D2r mRNA levels were measured by quantitative
real-time RT-PCR and are presented as relative
to the expression of the housekeeping gene
36B4, nWT = 9, nRxrg/ = 10 (A). In situ hybridiza-
tion detection of D2r mRNA is shown in the whole
striatum (left), and at high magnification in selected
regions (boxed) of the caudate putamen (CPu),
nucleus accumbens shell (NAcSh), and core
(NAcCo) in WT and Rxrg/ mice (B). The numbers
of D2r-positive cells in the shell and core of the
NAc are presented as relative to D2r cell counts
in the adjacent dorsal part of the CPu on the
same section, for nWT = 6 and nRxrg/ = 6 mice
(C). The effects of 19 days of chronic fluoxetine
treatment on the relative numbers of D2r positive
cells in NAcSh in nWT = 3 and nRxrg/ = 5 mice
were compared with nWT = 4 and nRxrg/ = 4
mice fed control diet (D). Data are presented as
mean values ± SEM. **p < 0.01; ***p < 0.001
different from corresponding WT group or ##, p <
0.01 for selected comparison. See also Figure S2.
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Retinoid Receptors Control Motivated Behaviorsexpression of the house keeping gene 36B4) were comparable
between Rxrg/ and their WT controls in the NAc (2.2 ± 0.4
for Rxrg/ and 2.7 ± 0.3 for WT; t = 1, ns) and hippocampus
(1.4 ± 0.2 for Rxrg/ and 1.9 ± 0.3 for WT mice; t = 1.5, ns).
To investigate functional relevance of abnormal serotonergic
signaling for depressive-like behaviors in Rxrg/ mice we
have tested whether acute fluoxetine treatment can reverse
increased despair in the forced swim test. In contrast to chronic
treatment, acute administration of fluoxetine at 20 mg/kg (IP,
30min prior to the forced swim test) did not alter increased
immobility of Rxrg/ mice as there was no significant interac-
tion for genotype 3 fluoxetine treatment (F[1,28] = 3E-4, ns)
and the main effect of genotype (F[1,28] = 19.4, p < 0.001) re-
mained significant despite of the treatment (Figure 3C). To
control for the efficiency of acute fluoxetine treatment we used
wild-type BALBcByJ (BALBc) mice, the strain susceptible to
reveal antidepressant activities of fluoxetine (Lucki et al.,
2001), and we found that 20 mg/kg of fluoxetine was sufficient
to significantly reduce despair behaviors in this strain
(Figure 3D). We concluded that inefficiency of acute fluoxetine
treatment to modulate despair behaviors suggests that
abnormal serotonergic signal is not sufficient to generate
depressive behaviors and adaptive changes associated with
chronic fluoxetine treatments might be at the origin of affective
abnormalities in Rxrg/ mice.Neuron 66, 908–9Reduced Dopamine D2 Receptor
Signaling in the Nucleus
Accumbens of Rxrg/ Mice Is
Reversible by Fluoxetine Treatment
The despair behavior and anhedonia and
their reversal by chronic antidepressant
treatment in Rxrg/ mice, indicates that
null mutation of Rxrg leads to deficits resembling some of the
core symptoms of depression. We hypothesized that abnormal
function of the nucleus accumbens (NAc), the key structure
implicated in the control of motivated behaviors and one of
the primary sites of Rxrg expression (Krezel et al., 1999) might
be at the origin of the behavioral abnormalities in Rxrg/
mice. As dopaminergic signaling in the NAc is critically involved
in the modulation of motivated behaviors and in the mechanisms
of antidepressant activities including fluoxetine, we examined
the expression of dopaminergic D1 and D2 receptors in Rxrg/
mice. Using real-time quantitative RT-PCR, we found a signifi-
cant 32% reduction of D2r expression in the NAc of Rxrg/
mice (t = 3.16, p < 0.01; Figure 4A). Interestingly, no such
reduction (t =0.22, ns) was observed in the dorsal caudate pu-
tamen (CPu). The inactivation of Rxrg did not affect expression of
D1r as D1r RNA levels were not significantly different between
WT and Rxrg/ mice in the NAc (11.7 ± 1.0 versus 10.6 ± 1.0
units; t = 0.76, ns) and dorsal striatum (37.2 ± 2.2 versus
39.9 ± 0.8 units; t = 1.35, ns), as measured by RT-PCR and
calculated relative to expression of a reference housekeeping
gene (Figure S2).
In order to further investigate the regionalization and the origin
of reduced levels of D2r mRNA in the NAc we carried out in situ
hybridization (ISH) studies (Figure 4B). Comparisons of Rxrg/
mice and their WT controls revealed that the number of neurons20, June 24, 2010 ª2010 Elsevier Inc. 911
Neuron
Retinoid Receptors Control Motivated Behaviorsexpressing D2r was significantly reduced in the shell of the NAc
(152 ± 4 versus 206 ± 6; t = 8, p < 0.001) and the core of the
NAc (294 ± 6 versus 338 ± 16; t = 2.44; p < 0.05), but not in
the dorsal striatum (798 ± 17 versus 841 ± 34; t = 1.1, ns). To
minimize cell counting errors related to differences in the signal
intensity between different sections, which may account for
more discrete changes, we took advantage of expression of
D2r in the dorsal striatum (CPu), which was not affected by abla-
tion of Rxrg/ and we used this region as our internal (intra-
section) control to calculate relative changes in D2r cell numbers.
To this end we divided cell counts in the NAcSh or NAcCo by
those obtained for the adjacent region of CPu on the same
section. We found a strong (36%) reduction in relative cell
number only in the NAcSh (0.16 ± 0.01 for Rxrg/ as compared
to 0.25 ± 0.02 for WT; t = 4.7, p = 0.001), but not in the NAcCo
(0.37 ± 0.01 for Rxrg/ versus 0.40 ± 0.02 for WT; t = 1.5, ns),
of Rxrg/ mice (Figure 4C). The difference in the magnitude of
changes in D2r expression might be related to much weaker
expression of Rxrg in the NAcCo as compared to shell region
(Krezel et al., 1999). Reduction of D2r in the NAcSh might be
functionally relevant as chronic fluoxetine treatment, in addition
to reversing depressive-like behaviors, increased also the rela-
tive number of D2r positive cells in the NAcSh of behaviorally
naive Rxrg/ mutants (0.15 ± 0.02 for nontreated Rxrg/
versus 0.23 ± 0.01 for fluoxetine treated Rxrg/ mice; t = 3.4,
p < 0.01), but not WT mice (0.24 ± 0.01 for nontreated WT
versus 0.27 ± 0.02 for fluoxetine treated mice; t = 1.2, ns;
Figure 4D).
A decrease of D2r-positive cell number in the NAcSh of
Rxrg/ mice is most probably related to reduced transcription
of D2r, rather than to the loss of a subpopulation of D2r
expressing neurons. Supporting this hypothesis, the number of
cells expressing mRNA coding for enkephaline, a neuropeptide
found predominantly in D2r expressing neurons, was not sig-
nificantly reduced (124.3 ± 2.8 enkephaline-positive cells in
the NAc shell of Rxrg/ mice, as compared to 133.6 ± 3 cells
in WT animals; t = 2.34, ns). Thus, the reduced number of
D2r-expressing neurons could reflect a general decrease of
D2r transcription in the NAc shell, with a reduction below the
detection threshold level in neurons expressing low levels of
D2r. Alternatively, it might be related to reduced transcriptional
control of D2r restricted to a selected neuronal population. To
address this issue, we quantified the intensity of D2r expression
in the ISH experiments, using the ImageJ software (see Experi-
mental Procedures). We found that the mean intensity of the
D2r signal in the NAc shell was not different between WT and
Rxrg/ mice when comparing absolute mean values (122.9 ±
2.2 for WT and 125.1 ± 2 for Rxrg/ mice; t = 0.7, ns) or when
such measures were normalized with respect to the intensity of
D2r expression in the dorsal striatum within the same brain
section, where D2r expression was not affected by ablation
of Rxrg (1.05 ± 0.01 for WT and 1.08 ± 0.02 for Rxrg/ mice;
t = 1, ns). These data suggest that Rxrgmight control expression
of D2r in a selected subpopulation of D2r neurons.
Finally, to assess whether cell- and regional-specific reduction
of D2r mRNA expression leads to abnormal D2r activities, we
investigated neuronal activation in Rxrg/ mice in response to
haloperidol, a D2 preferential antagonist. To this end, we studied912 Neuron 66, 908–920, June 24, 2010 ª2010 Elsevier Inc.the induction of c-fos protein expression, a molecular marker
related to neuronal activity and plasticity. An acute treatment
with haloperidol (1 mg/kg) increased the number of c-fos positive
cells in various regions of the striatum, including the shell and
core of the NAc and CPu in all tested mice (Figures 5A and
5B). However, in the shell of the NAc the magnitude of this
increase was significantly lower in the in Rxrg/ than in WT
mice as reflected by the significant interaction between geno-
type and treatment (F[1,14] = 5.6, p < 0.05) and PLSD Fischer
post hoc analysis (p < 0.01). Such difference was not observed
in the core of the NAc or in the dorsal CPu in the same sections
(compare NAc-Sh with NAc-Co and CPu for WT-Hal and KO-Hal
in Figure 5C). To study whether such a decrease reflects the
action of haloperidol or is related to the stress inflicted during
drug injection, we also evaluated the numbers of c-fos positive
cells in saline-injected mice and found that these numbers
were not significantly different between WT and Rxrg/ mice
(compare WT-veh and KO-veh in Figure 5C). Thus, the haloper-
idol-specific induction of c-fos in the shell of the NAc, calculated
as the ratio of c-fos positive cells in the haloperidol-treated
mice with respect to saline-treated mice, was lower by 48% in
Rxrg/ mice as compared to their WT controls (Figure 5D). To
validate these findings functionally we tested the locomotor
effects of low, non-cataleptic doses of haloperidol, which have
been proposed to involve post-synaptic dopamine D2 receptors
in the nucleus accumbens (Messier et al., 1992; Millan et al.,
2004; Pijnenburg et al., 1976). All mice treated with haloperidol
displayed reduction of locomotor activity in the novel environ-
ment of the open field, although such reduction was different
depending on the genotype (significant genotype 3 treatment
interaction, F[4,68] = 2.7; p < 0.05). Post hoc analysis revealed
that the decrease of locomotion was significantly lower in
Rxrg/ mice as compared to WT controls for haloperidol doses
of 0.1 and 0.2 mg/kg (p < 0.05; Figure 6A). These effects of halo-
peridol cannot be attributed to an altered susceptibility of
Rxrg/ mice to develop catalepsy, since a 0.2 mg/kg dose did
not induce catalepsy in WT and Rxrg/ mice, whereas a high
dose of haloperidol (2 mg/kg) induced comparable degrees of
catalepsy in both genotypes (Figure 6B).
Rxrg in the Nucleus Accumbens Is Critical for Control
of Despair and Hedonic Behaviors and Modulation
of D2r Expression
To investigate whether Rxrg expression in the nucleus accum-
bens shell plays a role in the control of depressive-like behaviors
and expression of dopamine D2r, we carried out functional
rescue experiments using stereotaxic injection of adenoassoci-
ated virus (AAV2) expressing Rxrg, in the NAc of Rxrg null
mutants. Using immunohistochemical analysis, we could clearly
detect the expression of Rxrg protein in the WT noninjected mice
(top panels in Figure 7A) or in the NAcSh ofRxrg/mice infected
with AAV2-Rxrg vector (bottom panels in Figure 7A), but not in
Rxrg/ animals infected with AAV2-Gfp virus (middle panels in
Figure 7A). The virus-mediated expression of Rxrg in Rxrg/
mice was detectable bilaterally at bregma 1.1 and 1.4 and
specifically in the NAcSh in 5 (out of 10) mice injected with
AAV2-Rxrg whereas for AAV2-Gfp infected mice, such pattern
of Gfp expression was identified in 7 (out of 10) animals. In the
NAcSh NAcCo CPu
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Figure 5. Haloperidol Induction of c-fos
Expression Is Impaired in the NAc Shell of
Rxrg/ Mutants
The brain regions used for c-fos counts are sche-
matized (A). c-fos positive cells were scored in
selected regions of the dorsal striatum (striped
area; CPu) (A), the nucleus accumbens shell
(NAcSh) and core (NAcCo) (B). c-fos-positive cells
were counted for each structure and are presented
as means ± SEM (C) or as the ratio of haloperidol/
vehicle induced c-fos cells for each genotype (D).
Each experimental group consisted of n = 6
animals. Data are presented as mean values ±
SEM. **p < 0.01, ###p < 0.001.
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Retinoid Receptors Control Motivated Behaviorsremaining animals (n = 5 for AAV2-Rxrg and n = 3 for AAV2-Gfp)
viral infection was unilateral or not restricted to the NAc (e.g.,
spreading into ventral septum) and these mice were excluded
from the analysis of behavioral data. The infection of Rxrg null
mutant mice with the AAV2-Rxrg expressing vector led to a
significant decrease of despair behaviors (t = 2.8, p < 0.05) and
anhedonia (t = 2.7, p < 0.05) as compared to Rxrg/ mice in-
fected with the Gfp-expressing virus (Figures 7B and 7C). Such
behavioral effects of Rxrg expression in the NAc were not
confounded by altered locomotor activity, as spontaneous loco-
motion in the actimetric cages or novelty induced locomotion in
the open field test were comparable between the groups
(Figure S3). During the sucrose preference test the total amount
of liquid consumed during the testing session was not different
among the groups and was on average 4.7 ± 0.4 mg/night.
In addition to reversal of behavioral deficits, re-expression of
Rxrg in the nucleus accumbens of Rxrg/ mice led to an
increase of the number of D2r expressing neurons. In the NAc
shell of Rxrg/ infected with AAV2-Rxrg we identified 190.2 ±
11.1 D2r-positive neurons, which was significantly more than
153.2 ± 11.2 neurons in AAV2-Gfp infected mutant mice (t =
2.34, p < 0.05), which was also reflected by relative measures
of D2v positive cell numbers with respect to adjacent CPu region
(0.23 ± 0.01 for AAV2-Rxrg as compared to 0.18 ± 0.01 in AAV2-
Gfp infected Rxrg/ mice; t = 3.1, p < 0.05). To addressNeuron 66, 908–9whether such an increase of D2v expres-
sion in the NAcSh is relevant to depres-
sive-like behaviors in Rxrg/ mice we
have blocked D2r signaling in the NAcSh
by bilateral infusion of the D2r antagonist
raclopride (5 mg/side) in AAV2-Rxrg
rescued Rxrg/ mice. We found that
blocking D2r signaling compromised
antidepressant effects of AAV2-mediated
re-expression of Rxrg in Rxrg/ mice
since such animals remained immobile
in the forced swim test for 130.6 ±
13.4 s, which was significantly longer
(t = 4.1, p < 0.01) thanRxrg/ mice which
were infected with AAV2-Rxrg and
infused with ACSF vehicle (57.9 ± 9.7 s;
Figure 7D). Although raclopride infusion
into the NAc led to a slight tendency toreduce general locomotor activity as measured in the open field
(Figure 7E), such reduction was not significant (t =0.87, p = 0.4)
and cannot account for increased immobility in the forced swim
test.
AAV2-Mediated Expression of D2r in the Nucleus
Accumbens Reverses Depressive-like Behaviors
of Rxrg/ Mice
In order to further address the role of a reduction of D2r expres-
sion in the control of depressive-like behaviors in Rxrg/ mice,
we increased D2r signaling in the nucleus accumbens by
AAV2 mediated expression of D2r. Seven out of nine injected
Rxrg/ mice were retained for statistical analysis as they dis-
played bilateral D2r expression revealed by increased number
of D2r positive neurons in the NAc (210.7 ± 10.5 in AAV2-D2r
mice as compared to 153.2 ± 11.2 in AAV2-Gfp infected
Rxrg/ mice; t = 4.3, p < 0.01). The increase of D2r-positive
neurons was specific to the shell of NAc and was not present
in the adjacent, dorsal part of the striatum on the same sections
(Figure 8A). Such expression was functionally relevant as it
increased locomotor activity in the open field (Figure 8B), which
attained 122.3 ± 10 m for AAV2-D2r mice as compared to 96.9 ±
3.7 m of distance covered by AAV2-Gfp mice (t = 2.35, p < 0.05).
Increased activity resulted from abnormal reactivity to a novel
environment and could be further demonstrated by increased20, June 24, 2010 ª2010 Elsevier Inc. 913
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Figure 6. Behavioral Responses to Haloper-
idol in Rxrg/ Mice
Twenty minutes after treatment with saline (0) or
haloperidol (0.1, 0.2, 1, or 2 mg/kg), locomotor
activity was measured in WT and Rxrg/ mice in
the open field test during 5 min. The number of
animals tested in each genotype/treatment
group was: nWT/0 = 7, nRxrg//0 = 7, nWT/0.1 = 8,
nRxrg//0.1 = 10, nWT/0.2 = 8, nRxrg//0.2 = 7,
nWT/1 = 7, nRxrg//1 = 7, nWT/2 = 7, nRxrg//2 =
10 (A). Catalepsy was measured in the bar test
30 min after vehicle (0) or haloperidol (0.2 or
2mg/kg) injection (B). The number of animals
tested in each genotype/treatment group was:
nWT/0 = 8, nRxrg//0 = 8, nWT/0.2 = 10, nRxrg//0.2 = 7,
nWT/2 = 8, nRxrg//2 = 8. Data are presented as
mean values ± SEM. *p < 0.05 with respect to WT
haloperidol-treated group.
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Retinoid Receptors Control Motivated Behaviorslocomotion in the actimetric cages, which was evident during the
first hr of the 32 hr test (Figure S3), thus reflecting enhanced D2r
signaling (Ouagazzal and Creese, 2000; Zhang et al., 1996). In
the forced swim test Rxrg/ mice infected with AAV2-D2r
remained immobile for 58 ± 11.1 s, which was significantly less
(t = 3.5, p < 0.01) than 127.9 ± 16.7 s for AAV2-Gfp mice
(Figure 8C). AAV2-mediated D2r expression also normalized
anhedonia of Rxrg/ mice. Indeed, Rxrg/ mice infected with
AAV2-D2r preferred sucrose to water and consumed 73.8% ±
6.9% of sucrose as opposed to significantly lower (t = 2.62,
p < 0.05), 53.3% ± 4.3% for AAV2-Gfp control mice (Figure 8D).
DISCUSSION
We provide here evidence that a specific retinoid receptor is
implicated in the control of affective behaviors in mice. We
show that null mutation of Rxrg leads to increased despair
behavior in the forced swim test and anhedonia, the key
symptom of depression as measured in the sucrose preference
paradigm. Our studies of single and compound Rxrg/ and
Rarb/ mutant mice provide also evidence that Rarb might
not be the heterodimerization partner of Rxrg in control of affec-
tive behaviors. Although we cannot exclude some functional
redundancy between Rar’s in their interactions with Rxrg, it is
unlikely that Rara or Rarg, the two other Rar isotypes, may func-
tionally compensate for the loss of Rarb, since these receptors
display very limited coexpression with Rxrg (Krezel et al.,
1999). Considering that in addition to Rar’s, the Rxr’s interact
with other members of the nuclear receptor superfamily, the
nature of the heterodimerization partner of Rxrg remains to be
determined.
The behavioral abnormalities displayed by Rxrg/ mice are of
particular relevance for research on depression, as they
resemble some of the core symptoms specific to depressive
disorders and they could be reversed by chronic fluoxetine treat-
ment. Such functions of Rxrg are specific to central control of
affective behaviors, since Rxrg null mutant mice do not present
dysfunction of the peripheral nervous system or muscles and
with the exception of compromised working memory (Wietrzych
et al., 2005), they do not display any other apparent abnormali-
ties (Krezel et al., 1996, 1998). Thus, considering efficiency of914 Neuron 66, 908–920, June 24, 2010 ª2010 Elsevier Inc.chronic treatment with fluoxetine to reverse anhedonia and
despair we speculated that abnormal serotonin signal might be
at the origin of depressive-like phenotype in Rxrg/ mice.
Although such hypothesis could be further supported by
increased 5HT tissue levels in the striatum and a strong tendency
(p = 0.08) for increased 5HT turnover in the hippocampus of
knockout mice, we found that acute modulation of serotonergic
signaling by single treatment with fluoxetine did not affect perfor-
mance of Rxrg/ mice in the forced swim test, suggesting
strongly that altered serotonin signaling is not sufficient to
generate depressive-like behaviors in these mice. In conse-
quence, we considered that long term, adaptive changes asso-
ciated with chronic fluoxetine treatment might be relevant for
beneficial effects of this antidepressant treatment and for the
mechanisms of depressive-like behaviors in Rxrg/ mice. We
investigated, therefore, dopaminergic signaling, known to be
modulated by chronic fluoxetine treatment and the key neuro-
transmission pathway involved in the control of motivated
behaviors. The dopamine D2 receptor has been suggested to
be particularly relevant to such regulations, and its potential
implication in depressive disorders and role in antidepressant
therapies have been investigated (Dailly et al., 2004; Millan,
2006; Nestler and Carlezon, 2006). In addition, D2r is known to
be a direct transcriptional target of retinoid receptors (Krezel
et al., 1998; Samad et al., 1997). We found that the inactivation
of Rxrg led to a significant reduction in D2r mRNA expression
specifically within the nucleus accumbens, whereas the expres-
sion of D1r was not affected in any part of the striatum. Interest-
ingly, our in situ hybridization analysis suggested that reduced
D2r expression may concern only a subpopulation of neurons
in the shell of NAc, since in this region (1) the number of enkepha-
line positive neurons, a distinct marker of D2r neurons was not
altered in Rxrg/ mice, (2) the intensity of D2r signal was not
reduced in D2r positive neurons of Rxrg/ mice indicating that
reduced D2r expression is not generalized, whereas (3) chronic
fluoxetine treatment increased the number of D2r positive
neurons in Rxrg/ mice, but not in WT mice.
At the moment, it is not clear why reduction of D2r expression
was not observed in the dorsal striatum of Rxrg/ mice, which
together with the shell of NAc are the brain regions with the
most prominent expression of Rxrg (Krezel et al., 1999). One
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Figure 7. Re-expression of Rxrg in NAc Shell Reverses Depressive-
like Behaviors in Rxrg/ Mice through D2r-Dependent Mechanism
Immunohistochemical detection of Rxrg in the dorsal caudate putamen (CPu)
and nucleus accumbens (NAc) shell of WT noninfected mice (A, top row) or
Rxrg/ mice after infection with AAV2 vector expressing Gfp (A, middle
row) or Rxrg (A, bottom row). Re-expression of Rxrg in the NAc shell
reduced immobility in the forced swim test (B) and restored sucrose prefer-
ence (C) in nRxrg/ = 7 mice as compared with nRxrg/ = 5 mice infected
with AAV2-Gfp. Acute inhibition of D2r signaling in the NAc shell after
bilateral infusion of raclopride (5 mg/side) prevented AAV2-Rxrg rescue of
depressive-like behaviors in Rxrg/ mice as measured in the forced swim
test for nraclopride = 5 and nACSF = 7 infused mice (D). Locomotor activity in
the open field test was studied in the same mice 2 days after forced swim
test (E). Data are presented as mean values ± SEM. *p < 0.05 in comparison
with Rxrg/ mice infected with AAV2-Gfp; **p < 0.01 in comparison with
ACSF infused control group. See also Figure S3.
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Figure 8. Expression of D2r in NAc Shell Reverses Depressive-like
Behaviors in Rxrg/ Mice
In situ hybridization detection of D2r transcripts in the dorsal caudate putamen
(CPu) and nucleus accumbens (NAc) shell of WT noninfected mice (A, top row)
or in Rxrg/ mice after infection with AAV2 vector expressing Gfp (A, middle
row) or D2r (A, bottom row). Expression of D2r in the NAc increased locomotor
activity during 30 min of the open field test (B). Antidepressant effects of D2r
expression were evidenced by reduced immobility in the forced swim test
(C) and restored sucrose preference (D) in Rxrg/ mice. The mean scores
for nAAV2-Gfp = 7 and nAAV2-D2r = 7 infected Rxrg
/ mice were presented ±
SEM. *p < 0.05; **p < 0.01 in comparison with Rxrg/ mice infected with
AAV2-Gfp. See also Figure S3.
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Retinoid Receptors Control Motivated Behaviorspossible explanation is that transcriptional control of D2r expres-
sion in the dorsal striatum is subject to marked functional redun-
dancy between Rxrg and Rxra and/or Rxrb. Such hypothesis is
supported by an overall reduction of striatal D2r expression
and severe locomotor deficits displayed by Rxrb/Rxrg double
null mutants, these defects being absent in the corresponding
single null mutants (Krezel et al., 1998).
The reduction of D2r mRNA expression in the NAc of Rxrg/
mice is relevant for D2r functions, as we observed that c-fos
induction by haloperidol treatment, a D2r antagonist was blunted
in mutant mice. In concordance with the topography of deficits in
D2r expression, reduced activation of c-fos expression was
observed in the shell of the NAc, indicating that the reduction
of D2r functions might be restricted to this region of the ventral
striatum. Such observations are further supported by a bluntedNeuron 66, 908–920, June 24, 2010 ª2010 Elsevier Inc. 915
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Retinoid Receptors Control Motivated Behaviorslocomotor response ofRxrg/ mice to low, noncataleptic doses
of haloperidol. Thus, Rxrg null mutant mice were less prone to
reduction of locomotor activity in response to haloperidol treat-
ment, suggesting compromised D2r responsiveness in the
ventral striatum, the region strongly implicated in the control of
horizontal locomotion (Amalric and Koob, 1993; Messier et al.,
1992; Pijnenburg et al., 1976; Zhang et al., 1996).
Reduced D2r signaling in Rxrg/ mice might be directly
related to depressive-like deficits displayed by these mice. In
line with this hypothesis, we found that chronic fluoxetine
reversal of depressive-like behaviors was accompanied by an
increase of D2r expression in the NAcSh of Rxrg/ mice. To
further explore the behavioral relevance of compromised D2r
signaling in Rxrg/ mice and the implication of Rxrg in such
control, we carried out rescue experiments by virus-mediated
re-expression of Rxrg in Rxrg/ mice. We found that
re-expression of Rxrg in the shell of NAc is critical for modulation
of D2r expression and affective behaviors. This was illustrated by
an increase of the number of D2r expressing neurons in the NAc
and a reversal of behavioral deficits in the forced swim and
sucrose preference tests following AAV2 mediated re-expres-
sion of Rxrg in the NAc of Rxrg/ mice. An increase of D2r
expression in NAc appeared to play a critical role in
the antidepressant-like activities of Rxrg, since infusion of
raclopride, a D2r/D3r antagonist, prevented the rescue of
despair behaviors in Rxrg/ mice infected with AAV2-Rxrg.
Furthermore, we showed that a long-lasting increase of D2r
signaling by AAV2 mediated expression of D2r in the NAcSh of
Rxrg/ mice reversed both despair behaviors in the forced
swim and anhedonia in the sucrose preference test. The func-
tionality of viral expression of D2r was confirmed by an increased
number of D2r neurons, but also by an increase in novelty
induced locomotion as tested in the open field or actimetric ca-
ges, which is in agreement with stimulating locomotor effects
D2r activation in NAc (Ouagazzal and Creese, 2000; Zhang
et al., 1996). Interestingly, such increased locomotion was not
observed following re-expression of Rxrg in Rxrg/ mice even
though it also increased expression of D2r. Such difference
might be related to quantitative and qualitative differences in
D2r expression, which might have been stronger and display
distinct, cell type-specific activities after infection with AAV2-
D2r as compared to mice infected with AAV2-Rxrg. Although
such increased activity may confound results of the forced
swim test, we suggest that reduced immobility, induced by
AAV2-mediated expression of D2r in Rxrg/ mice reflects anti-
depressant activities since (1) inhibition of D2r signaling by ra-
clopride, which prevented AAV2-Rxrg rescue of despair behav-
iors in Rxrg/ mice, was devoid of nonspecific behavioral
effects on locomotion as measured in the open field test; (2) viral
expression of D2r also normalized anhedonia in Rxrg/ mice,
a distinct measure of depressive-like behaviors, not affected
by locomotor side effects of AAV2-D2r infection. Finally, consid-
ering that AAV2 infections lead to low levels of retrograde trans-
duction (Paterna et al., 2004), our data on antidepressant effects
of AAV2-D2r infection of Rxrg/ mice suggest the role of post-
synaptic D2r in NAc in control of affective behaviors.
In conclusion, this study provides the first evidence that the
loss of Rxrg signaling leads to depressive-like behaviors in mice916 Neuron 66, 908–920, June 24, 2010 ª2010 Elsevier Inc.and indicates that decreased dopamine D2r signaling in the shell
of the NAc plays a critical role in Rxrg control of affective behav-
iors. Considering that retinoids or n-3 PUFAs (de Urquiza et al.,
2000; Lengqvist et al., 2004; M.W. et al., unpublished data) can
modulate Rxr activities in vitro and in vivo, the present data might
be of direct relevance for antidepressant activities of n-3 PUFAs
reported in clinical conditions (Logan, 2004; Peet and Stokes,
2005) or depression associated with isotretinoin treatment
(Bremner and McCaffery, 2008; Kontaxakis et al., 2009). In addi-
tion, mnemonic deficits specific to working memory, which were
described in Rxrg/ mice (Wietrzych et al., 2005) might be
relevant to cognitive deficits associated with depression. Such
deficits, although not considered as the core symptoms of
depression, are found in most forms of clinical depression.
Consequently, our data suggest that Rxrg is a potential novel
target for antidepressant treatments. Unlike conventional neuro-
pharmacology, treatments targeting retinoid receptor(s) could
modulate availability of specific neurotransmitter receptors by
fine, transcriptional control of their expression. Thus, Rxr ligands
such as bexaroten (Targretin), used so far in cancer treatment,
might be potentially interesting for clinical trials in treatment of
depressive disorders.
EXPERIMENTAL PROCEDURES
Animals
Rarb/ and Rxrg/ single mutant, and Rarb/Rxrg/ double mutant male
mice as well as their wild-type (WT) control mice were raised on a mixed
genetic background (60% C57BL/6J and 40% 129SvEms/j) from heterozy-
gous crosses as described (Krezel et al., 1996), and tested at the age of
4–5 months. All mice were housed in groups of 4–5 mice per cage in a
7 a.m.–7 p.m. light/dark cycle in individually ventilated cages, type ‘‘MICE’’
(Charles River, France). Food and water were freely available. All experiments
were carried out in accordance with the European Community Council
Directives of 24 November 1986 (86/609/EEC) and in compliance with the
guidelines of CNRS and the French Agricultural and Forestry Ministry (decree
87848).
Behavioral Procedures
Forced Swim Test
The forced swim paradigm (Dalvi and Lucki, 1999) was carried out between
1 p.m. and 4 p.m. in a 2-l glass beaker half-filled with water at 22C–23C
(the water depth was 15 cm). All mice were tested only once in this task. To
this end, each mouse was lowered gently into the water and the time of immo-
bility was scored during a 6 min testing period. The mouse was judged immo-
bile when it floated in an upright position and made only small movements to
keep its head above the water. After 6 min, the mouse was taken out of the
water, left to dry under a red light lamp and returned to its home cage.
Sucrose Preference Test
This task, designed to measure hedonic behaviors in mice (Moreau, 1997;
Nestler et al., 2002), is based on the palatable nature of sucrose observed in
a number of mouse strains. Mice were first habituated to experimental condi-
tions by an overnight housing in individual cages equipped with one bottle
filled with water. On the first day of the test, sucrose-naive mice were placed
at 5 p.m. in the same individual cages with one bottle filled with water and
another with 1% sucrose solution. Three hours later (8 p.m.) the bottles were
weighed to measure liquid consumption and were replaced in cages until
morning to continue habituation to experimental conditions. Over 2 additional
days, animals were further habituated to sucrose solution in their home cages.
The measures of an overnight consumption were then carried out from 5 p.m.
until 8 a.m. to evaluate sucrose preference. Mice were not water deprived at
any moment, in order to measure spontaneous sucrose preference and
exclude any potential emotional confounds induced by stress of water
Neuron
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solution consumed with respect to total liquid consumption.
Actimetry
Spontaneous activity was measured in actimetric cages (Immetronic, Pessac,
France) with the help of two arrays of infrared beam photo-cells installed on
the side walls in each individual cage. Mice were placed in actimetric cages
at 11 a.m. and their activity was recorded over 32 hr including a habituation
period between 11 a.m. and 7 p.m. and a complete dark/light cycle until
7 p.m. of the next day.
Open Field
Mice were tested in parallel in five automated open-fields (44.3 3 44.3 3
16.8 cm) made of PVC with transparent walls and a black floor, covered with
transparent PVC (Panlab, Barcelona, Spain). The open fields were placed in
a room homogeneously illuminated at 150 Lux. Unless otherwise specified
each mouse was placed in the periphery of the open field and allowed to
explore freely the apparatus for 30 min, with the experimenter out of the
animal’s sight. Activity parameters including distance traveled over the test
session were calculated automatically.
Catalepsy Test
Mice were injected intraperitoneally with 0.2 or 2 mg/kg of haloperidol (Sigma)
and after 30 min were placed in the test cage with their forelimbs on the
wooden transversal bar fixed at a level of 3 cm above floor level. The latency
to move out from the bar was scored and used as index of catalepsy.
Production and Use of Adenoassociated Virus (AAV) Vectors
For generation of AAV vectors we used a vector plasmid containing an expres-
sion cassette, in which a human cytomegalovirus immediate-early promoter
(CMV promoter) was followed by the first intron of the human growth hormone
gene, the cDNA of interest, woodchuck hepatitis virus posttranscriptional
regulatory element (WRPE; nucleotides 1093 to 1684, GenBank accession
number J04514) and simian virus 40 polyadenylation signal sequence. This
expression cassette was inserted between the inverted terminal repeats
(ITR) of the AAV-2 genome as described (Li et al., 2006). The viral vectors
used for expression of Rxrg (AAV2-Rxrg), D2r (AAV2-D2r), and EGfp (AAV2-
Gfp) contained the entire cDNA sequences of Rxrg (GenBank accession
number NM_009107), D2r (long isoform, GenBank accession number
NM_010077.2), or EGfp, respectively. We used two helper plasmids, pAAV-
RC and pHelper, harboring the AAV rep and cap genes, and the E2A, E4,
VA1 genes of the adenovirus genome, respectively (Agilent Technologies,
Santa Clara, CA). HEK293 cells were cotransfected with pAAV-RC and
pHelper plasmids using the calcium phosphate coprecipitation method. AAV
particles were then harvested and purified by two sequential continuous
iodoxale ultracentrifugations. The vector titer was determined by quantitative
PCR of DNase-I-treated vector stocks, and were estimated at 1010 to 1012
vector genome copies (vg).
For rescue experiments and D2r expression we used behaviorally naive
Rxrg/ male mice (n = 29) at the age of 8 months. Each animal was anaesthe-
tized using ketamine (100 mg/kg)/xylasine (10 mg/kg) solution and 0.7 ml of
AAV2-Rxrg, AAV2-D2r, or AAV2-Gfp suspension was injected bilaterally
into the nucleus accumbens (bregma = +1.5; lateral = ±0.7; ventral = +4.2,
the coordinates identified prior to experiments using dye injections and
corresponding to bregma = + 1.3; lateral = ±0.5; ventral = +4.0 position in
the Mouse Brain Atlas; Paxinos and Franklin, 2001) using a stereotaxic appa-
ratus (Precision Cinematographique, Paris, France). The injection was carried
out at 50 nl/min using a Harvard Apparatus PHD 2000 pump (Holliston, USA),
and the injectors were withdrawn from the brain 20 min after the end of the
injection. After placing stitches each animal was left to awake in the tempera-
ture-conditioned cage. Mice were tested 4 weeks later and their brains were
removed for post hoc analyses.
Drug Infusion Procedure
Rxrg/ mice (n = 15) aged between 4 and 5 months were infected with AAV2-
Rxrg as described. Four weeks later, mice were anaesthetized with ketamine/
xylazine solution and 8 mm long stainless-steel guide cannulas (0.4 mm
external diameter; Cortat, Courrendlin, Switzerland), were positioned bilater-
ally 1 mm above the NAcSh (bregma = +1.5; lateral = ±0.7; ventral = +3.2) using
stereotaxic apparatus (Precision Cinematographique, Paris, France). Thecannulas were fixed to the skull with anchoring screws and dental cement.
Stainless steel stylet rods were inserted into the cannulas to prevent occlusion.
On the day of the experiment raclopride (a D2/D3 specific antagonist soluble in
aqueous solutions; Sigma) was dissolved in fresh artificial cerebrospinal
fluid (ACSF, which consisted of 3 mM KCl, 140 mM NaCl, 2 mM glucose,
1.2 mM CaCl2, 1 mM MgCl2, 0.27 mM NaH2PO4, 1.2 mM Na2HPO4 [pH 7.4])
and infusions of 0.25ml of raclopride (5 mg/side) or vehicle (ACSF) were per-
formed at 100 nl/min using Harvard Apparatus PHD 2000 pump and stain-
less-steel injector needles (0.28 mm external diameter) that protruded from
the cannula by 1 mm, into the NAcSh. Three minutes after injection injector
needles were removed from the brain, the stylet rods were replaced in cannula
guides and mice were transferred to their home cage for 5 min prior to the
forced swim test. Forty-eight hours later, mice were semirandomly infused
with raclopride or ACSF to test the locomotor effects of such treatments.
For this experiment mice were placed in the open field immediately after
removing injectors and placement of stylet rods and their activity was scored
5 min later during 5 min. Three out of fifteen mice were excluded from analysis
due to unilateral AAV2-Rxrg infection or incorrect guide placement, and two
mice could not be infused for the open field test since the stylets remained
blocked.
Pharmacological Treatments
Haloperidol (Sigma-Aldrich) was dissolved in acetic acid solution and pH was
neutralized with NaOH. For c-fos expression studies, mice were injected intra-
peritoneally (IP) with saline or 1 mg/kg of haloperidol, 90 min prior to sacrifice,
whereas for analysis of the open field behavior saline or haloperidol were
injected 20 min prior to the test and animals were tested for 10 min. IP injection
was also used for acute fluoxetine (Lilly France) treatment 30 min prior to
forced swim test. For chronic treatment, fluoxetine was added to the standard
chow diet. Accordingly, we supplemented standard chow in powdered form
with fluoxetine to attain the dose of 20 mg of fluoxetine per kg of body weight
during 24 hr. To calculate such a dose, the food consumption was first esti-
mated experimentally to be 4 g of food pellets per 24 hr per animal. Fluoxe-
tine-supplemented food pellets were immediately lyophilized and stored
at 20C until use. For treatment, standard chow pellets were replaced by
fluoxetine-supplemented food pellets and were provided ad libitum in
standard home cages throughout treatment period. The consumption of
fluoxetine-containing pellets did not differ from the consumption of nonsupple-
mented food pellets in control cages. WT and Rxrg/ mice treated with
fluoxetine or fed control diet were all tested for sucrose preference on the nine-
teenth day of treatment, and in the forced swim test on the twenty-first day of
treatment, with the exception of mice used for evaluation of fluoxetine effects
on D2r expression, which were all behaviorally naive.
Quantitative RT-PCR
Dissection of Brain Areas
Mice were killed by cervical dislocation. Whole brains were extracted, fresh-
frozen in OCT, and kept at 80C until use. Tissue corresponding to the
nucleus accumbens (NAc) was collected with 0.5 mm punch from three subse-
quent 300 mm thick cryosections. Similarly, dorsolateral striatum (CPu) was
collected using 0.8 mm punch from four subsequent frozen sections of
300 mm. The accurate location of these brain structures was based on
visual inspection of each section using a stereomicroscope (Leica, Wild
M715) and its comparison with the stereotaxic atlas of mouse brain; Paxinos
and Franklin, 2001). Tissue samples were placed on dry ice and kept
at 80C until use.
Quantitative RT-PCR
Total RNA extraction was carried out using the RNeasy Micro Kit protocol
(QIAGEN, France). Total RNA from each tissue sample was transcribed
into cDNA using QuantiTect Reverse Transcription Kit according to the manu-
facturer’s recommendation. Briefly, the reaction was carried out at 42C for
20min in a total volume of 20 ml and was inactivated at 95C. Twenty-times-
diluted cDNA was used as a template, and quantitative real-time PCR was
run in a LightCycler 480 (Roche, Diagnostics, Mannheim, Germany) using
LightCycler SYBR Green kit (Roche, Diagnostics) with cDNA and gene-
specific primers (100 mM) following the manufacturer’s instructions. All
of the reactions were performed in triplicate with the following cyclingNeuron 66, 908–920, June 24, 2010 ª2010 Elsevier Inc. 917
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turation at 95C for 5 s, annealing at 60C for 30 s, and extension at 72C for
20 s. Fluorescence detection was performed at 72C. Gene-specific primers
were designed using Primer3 software (primer3) to amplify fragments of
150–250 bp as follows: for D2r (Drd2; NM 010077) forward, TCGCC
ATTGTCTGGGTCCTG; reverse, TGCCCTTGAGTGGTGTCTTC; D1r (Drd1a;
NM 010076) forward, AAGATGCCGAGGATGACAAC; reverse, CCCTC
TCCAAAGCTGAGATG. The transcript amounts evaluated for D1r and D2r
were normalized for the quantity and quality of each sample by division by
the amount of transcript of the housekeeping gene acidic ribosomal phospho-
protein P0 (Arbp or 36B4; NM 007475) in the same sample and such relative
values were presented in Figures 4A and 2S. 36B4 transcript amount was
quantified using forward primer ACCCTGAAGTGCTCGACATC and reverse
primer AGGAAGGCCTTGACCTTTTC.
In Situ Hybridization and Analysis of Expression Levels
In situ hybridization (ISH) was performed on 14 mm thick frozen sections with
digoxigenin-labeled riboprobes synthesized from a 1680 bp D2r cDNA
template and an enkephaline 800 bp cDNA template as described (Krezel
et al., 1998). Hybridization conditions were as described previously (Krezel
et al., 1998) and are available on the http://empress.har.mrc.ac.uk/ website.
The amount of probe used for hybridization and signal detection conditions
was adapted to avoid saturation of the chromogenic labeling (see below).
Expression patterns were documented using a macroscope (Leica M420) or
microscope (DM4000B), both connected to a Photometrics camera with the
CoolSNAP (v. 1.2) software (Roger Scientific, Chicago, IL).
For the analysis of cell counts and expression levels of D2r, the images were
transformed into gray scale and analyzed using ImageJ software (Rasband,
1997). The strongest signal observed for any of the neurons in any of the brain
sections remained between 67 and 95 units in a 0 to 255 unit gray scale (0 cor-
responding to black), being thus 25%–30% below full saturation conditions in
order to enable quantitative analysis of signal intensity. For each animal, the
cell number and intensity of cellular signal was evaluated within selected
regions of CPu, NAcSh and NAcCo on the same sections (for region selection
see Figures 5A and 5B) at bregma 1.10 and 1.40 (Paxinos and Franklin, 2001).
The mean values of cell counts or intensity for each region were calculated and
compared as described in Results.
Immunohistochemistry and c-fos Cell Counts
Coronal sections (14 mm thick) from unfixed frozen brains of 4-month-old
Rxrg/ mice and their WT littermates were collected on super-frost
slides and stored at –80C until analysis. Sections were postfixed in 4% para-
formaldehyde and treated with 1% H2O2 to block endogenous peroxides. For
detection of Rxrg, we used rabbit anti-Rxrg polyclonal antibody (SC555, batch
A111, Santa Cruz, US), whereas c-fos was detected using rabbit anti-c-fos
polyclonal antibody (1:1000, Chemicon). Both primary antibodies were de-
tected using the ABC system (Vector, USA) according to the manufacturer’s
manual. For each animal and section, corresponding brain regions were iden-
tified according to the mouse brain atlas (Paxinos and Franklin, 2001) and
c-fos-positive cells were counted from identical surfaces defined by region-
corresponding auto-shape figures (Figures 5A and 5B) at two levels of the
striatum (bregma 1.10 and 1.40; Mouse Brain Atlas; Paxinos and Franklin,
2001). The mean cell counts for each brain region were calculated and
compared as described in Results.
HPLC Measures of Serotonin and Its Metabolites in the Brain Tissue
The brain samples of n = 6 WT and n = 6 Rxrg/ male littermates (4months
old) were weighed immediately after collection and frozen at 80C until use.
Before analysis, samples were thawed, and homogenized in 10 volumes (w/v)
of 0.1 M HClO4 containing the internal standard DHBA (125ng/ml). The
homogenates were centrifuged at 12.000 rpm for 20 min at 4C and
supernatant was retained for analysis. Serotonin and its metabolite 5-hydrox-
yindoleacetic acid (5HIAA) were evaluated using high performance liquid
chromatography (HPLC) with electrochemical detection. The chromato-
graphic system consisted of a 25 cm 3 4.6 mm Hypersyl C18 ODS column
(particle size 5mm, Biochrom, France). The column was kept at a constant
temperature of 30C. The flow rate was 1.2 ml/min with a back pressure of918 Neuron 66, 908–920, June 24, 2010 ª2010 Elsevier Inc.1500 psi (Waters Instrumentation). The system was linked to a Waters model
460 electrochemical detector with a glassy-carbon electrode. Detector
potential was maintained at 0.85 V (reference, Ag/AgCl electrode). The
mobile phase consisted of 0.05 M NaH2PO4 and 0.1 mM EDTA (pH adjusted
to 4.85 with NaOH) in double-distilled water with methanol (6%). The system
was calibrated by injecting various amounts (3.4 pg–34 ng) of standard
solutions, containing 1.1 ng of internal standard DHBA (3–4 dihydroxybenzyl-
amine 1 mM in HClO4 0.1 M). The supernatant of each sample was injected
onto the column, and peak identification was performed by comparing
retention times with the calibration solution. Results were expressed in
ng/g ±SEM.Statistical Analysis
The comparisons of behavioral performance in Rarb//Rxrg/, Rarb/, and
Rxrg/ null mutant mice were carried out using the protected least significant
difference (PLSD) Fischer test. The pharmacological data for the treatments
in WT and Rxrg/ mice were analyzed using two-way analysis of variance
(ANOVA)—with treatment and genotype as two independent factors and
behavioral responses as dependent variables. Comparison of the evolution
of locomotor performance in the open field or actimetric cages were evaluated
using ANOVA on repeated-measures. Global and post hoc statistical analyses
were performed using the PLSD Fischer test and for two-group comparisons
using student t test (see t values in the text). Significant differences are indi-
cated in the corresponding figures.SUPPLEMENTAL INFORMATION
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